Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Director departure

RVL Pharmaceuticals plc (OSMT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2023 4 Lask Alisa (Director) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 12,000 shares @ $0.49, valued at $5.9k
07/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2023 4 COWAN GREGORY L (Director) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Granted 40,000 shares @ $0
07/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2023 4 Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 5,577 shares @ $0.87, valued at $4.9k
05/22/2023 4 Klein Christopher (General Counsel & Secretary) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 5,447 shares @ $0.87, valued at $4.7k
01/30/2023 4 Burgstahler David F (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Disposed of 1,032,995 shares @ $0
01/30/2023 4 Venkataraman Sriram (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Disposed of 1,032,995 shares @ $0
01/30/2023 4 Avista Capital Partners III GP, L.P. (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Disposed of 1,032,995 shares @ $0
01/26/2023 4 Klein Christopher (General Counsel & Secretary) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,608 shares @ $1.26, valued at $12.1k
01/26/2023 4 Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,608 shares @ $1.26, valued at $12.1k
08/12/2022 4 Lask Alisa (Director) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Granted 75,000 shares @ $0
08/09/2022 4 Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Bought 150,000 shares @ $1.55, valued at $232.5k
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Burgstahler David F (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Bought 8,000,000 shares @ $1.55, valued at $12.4M
08/09/2022 4 Venkataraman Sriram (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Bought 8,000,000 shares @ $1.55, valued at $12.4M
08/09/2022 4 Avista Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Bought 8,000,000 shares @ $1.55, valued at $12.4M
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2022 4 Einhorn Andrew J. (CFO) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,607 shares @ $1.13, valued at $10.9k
01/26/2022 4 Klein Christopher (General Counsel & Secretary) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,607 shares @ $1.13, valued at $10.9k
01/26/2022 4 deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,607 shares @ $1.13, valued at $10.9k
01/26/2022 4 Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc
Txns: Paid exercise price by delivering 9,607 shares @ $1.13, valued at $10.9k
12/20/2021 4 Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Bought 93,800 shares @ $1.07, valued at $100.4k
11/08/2021 4 deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 216,944 options to buy @ $1.8, valued at $390.5k
11/08/2021 4 Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 249,814 options to buy @ $1.8, valued at $449.7k
11/08/2021 4 Klein Christopher (General Counsel & Secretary) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 249,814 options to buy @ $1.8, valued at $449.7k
11/08/2021 4 Einhorn Andrew J. (CFO) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 249,814 options to buy @ $1.8, valued at $449.7k
11/08/2021 4 MARKISON BRIAN A (CEO) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 615,000 options to buy @ $1.8, valued at $1.1M
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2021 4 WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc
Txns: Granted 61,188 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy